Biocardia stock.

BioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules. SUNNYVALE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA] (the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today …Richard has made over 43 trades of the BioCardia stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of BCDA stock worth $14,600 on 17 June 2019.Biocardia Inc stock performance at a glance. Check Biocardia Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.November 15, 2023 at 8:04 AM · 3 min read. Shares of BioCardia BCDA skyrocketed 168.2% on Tuesday after management announced that the FDA approved its proposed late-stage CardiAMP Heart Failure ...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for BioCardia Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate ... Biocardia Stock Ownership FAQ. Who owns Biocardia? Biocardia ( NASDAQ: BCDA) is owned by 7.68% institutional shareholders, 908.30% Biocardia 0.00% retail investors. Phillip Md Et Al Frost is the largest individual Biocardia shareholder, owning 151.76M shares representing 701.96% of the company. Phillip Md Et Al Frost's Biocardia shares …

Nov 14, 2023 4:51 AM PST. By Dean Seal. Shares of BioCardia more than doubled after the company said regulators have approved a Phase 3 trial of its CardiAMP treatment for patients with ischemic ...

Nov 16, 2023 · SUNNYVALE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA] (the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ... BioCardia announces $1.3M registered direct offering priced at-the-market. The Fly • 17 days ago. Track BioCardia Inc. (BCDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.6 hari yang lalu ... BioCardia, Inc., headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of ...The BioCardia, Inc. stock price fell by -0.92% on the last day (Wednesday, 29th Nov 2023) from $0.686 to $0.680. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 11.30% from a day low at $0.639 to a day high of $0.711. The price has fallen in 8 of the last 10 days and is down by -36.45% for this period.What this means: Biocardia Inc (BCDA) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

NRBO. Neurobo Pharmaceuticals Inc. 0.442. -0.006. -1.3393%. Get BioCardia Inc (BCDA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

BioCardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange. Acute Myocardial Infarction Patients Treated Early With Cell Therapy …

Find the latest BioCardia, Inc. (BCDA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 書名：Price-Forecasting Models for Biocardia Inc BCDA Stock，ISBN：9798731444187，出版社： Independently published，作者：Ton Viet Ta，頁數：， ...Get the latest BioCardia (BCDAW) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ... Stock Market ... Richard has made over 43 trades of the BioCardia stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 20,000 units of BCDA stock worth $14,600 on 17 June 2019.Mr. McClung BCDA stock SEC Form 4 insiders trading. David has made over 5 trades of the BioCardia stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,600 units of BCDA stock worth $4,096 on 5 November 2018.1,600 units of BCDA stock worth $4,096 on 5 November 2018.In this article. BioCardia Inc (NASDAQ: BCDA) shares are down after the company released interim efficacy results in the phase 3 pivotal CardiAMP cell therapy heart failure trial. For the first ...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...

Pursuant to the Purchase Agreement, the Company agreed to sell to the Investors an aggregate 2,122,017 shares of the Company’s common stock at an offering price of $1.68 per share, the average ...Mr. McClung BCDA stock SEC Form 4 insiders trading. David has made over 5 trades of the BioCardia stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,600 units of BCDA stock worth $4,096 on 5 November 2018.1,600 units of BCDA stock worth $4,096 on 5 November 2018.The gross proceeds to BioCardia, before deducting fees and other offering expenses, are expected to be approximately $3.6 million. The closing of the sale of the securities is expected to occur on ...BioCardia, Inc. Common Stock (BCDA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Allan Tessler BCDA stock SEC Form 4 insiders trading. Allan has made over 11 trades of the BioCardia stock since 2006, according to the Form 4 filled with the SEC. Most recently Allan bought 400 units of BCDA stock worth $199,200 on 9 March 2020.. The largest trade Allan's ever made was buying 20,000 units of BioCardia stock on 21 …Nov 17, 2023 · Source. Headline. Genocea Biosciences (NASDAQ:GNCAQ) vs. BioCardia (NASDAQ:BCDA) Financial Analysis. americanbankingnews.com - November 17 at 1:30 AM. BioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules. finance.yahoo.com - November 16 at 3:00 PM.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for BioCardia Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate ... Nov 14, 2023 4:51 AM PST. By Dean Seal. Shares of BioCardia more than doubled after the company said regulators have approved a Phase 3 trial of its CardiAMP treatment for patients with ischemic ...

BioCardia Inc. Stock Earnings. The value each BCDA share was expected to gain vs. the value that each BCDA share actually gained. BioCardia Inc. ( BCDA) reported Q2 2023 earnings per share (EPS) of -$0.17, missing estimates of -$0.16 by 7.23%. In the same quarter last year, BioCardia Inc. 's earnings per share (EPS) was -$0.14.SUNNYVALE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA] (the “Company”), a developer of cellular and cell-derived therapeutics …BioCardia Stock Up 8.2 %. NASDAQ BCDA opened at $0.67 on Friday. The firm’s fifty day moving average price is $0.50 and its two-hundred day moving average price is $1.17. BioCardia has a 1 year ...Mohammed Haneefa Nizamudeen. I first wrote about BioCardia (NASDAQ:BCDA) in June of 2021, explaining why I'd taken a speculative-sized position in the stock.Since then the share price is down (as ...BioCardia, Inc. (BCDA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Stock screener. Filter, compare, and track stocks. Insiders trading. See how executives trade. Heat map. Visualize ratios & metrics. Histogram. See ratios across industries. ... As the Vice President - Operations of BioCardia, the total compensation of Phil Pesta at BioCardia is $276,000.BioCardia Inc. (NASDAQ:BCDA) trade information. BioCardia Inc. (BCDA) registered a 8.23% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 8.23% in intraday trading to $0.67 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -5.22%, and it has moved by 77.43% in ...

Biocardia. stock was originally listed at a price of $1,738.17 in Dec 31, 1997. If you had invested in Biocardia stock at $1,738.17, your return over the last 25 years would have been -99.96%, for an annualized return of -27.08% (not including any dividends or dividend reinvestments).

Nov 24, 2023 · BioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules SUNNYVALE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA] (the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmo...

Nov 14, 2023 · BioCardia ( NASDAQ: BCDA) shares jumped over +105% premarket on Tuesday after the biotech firm received FDA approval for the Phase 3 clinical trial of its CardiAMP autologous cell therapy for the ... In this article. BioCardia Inc (NASDAQ: BCDA) shares are down after the company released interim efficacy results in the phase 3 pivotal CardiAMP cell therapy heart failure trial. For the first ...BioCardia announces $1.3M registered direct offering priced at-the-market. The Fly • 17 days ago. Track BioCardia Inc. (BCDA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Earnings for BioCardia are expected to decrease in the coming year, from ($0.54) to ($0.56) per share. BioCardia has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off prior year's report dates. Read More.BioCardia Inc. (NASDAQ:BCDA) trade information. BioCardia Inc. (BCDA) registered a 8.23% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 8.23% in intraday trading to $0.67 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -5.22%, and it has moved by …The Wall Street analyst predicted. that Biocardia's share price could reach $4.00 by Nov 14, 2024. The average Biocardia stock price prediction forecasts a potential upside of 495.24% from the current BCDA share price of $0.67.Biocardia Inc stock performance at a glance. Check Biocardia Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.The BioCardia stock prediction for 2025 is currently $ 139.62, assuming that BioCardia shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 20,667.78% increase in the BCDA stock price.The estimated Net Worth of Peter Altman is at least $883 Thousand dollars as of 28 June 2019. Peter Altman owns over 600 units of BioCardia stock worth over $205,985 and over the last 5 years he sold BCDA stock worth over $0. In addition, he makes $677,501 as President, Chief Executive Officer, and Director at BioCardia.

Nov 15, 2023 · BioCardia Inc’s (NASDAQ: BCDA) stock has experienced a remarkable surge of 225.70% following the FDA’s recent approval of the Phase 3 CardiAMP Heart Failure II study protocol for their innovative CardiAMP autologous cell therapy for ischemic heart failure. A new COVID variant, HV.1, is now dominant. These are its most common symptoms. Deer hunting is dying. That should worry you even if you don't hunt. The FDA approved BioCardia Inc's (NASDAQ: BCDA ...Nov 7, 2023 · BCDA Stock Shows Promising Performance with Potential 863.86% Increase: Analysts Recommend Buying BioCardia Inc. BCDA stock has shown promising performance on November 7, 2023, according to data sourced from CNN Money. The median target price is $4.00, indicating a potential increase of 863.86% from the last recorded price of $0.42. Instagram:https://instagram. what leverage does forex.com offerwhen to preorder iphone 15best dollar5000 investmenttoyota motors stock BioCardia, Inc. (BCDA) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.7050 +0.0565 (+8.71%) At close: 12:59PM EST 0.6800 -0.03 (-4.13%) …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for BioCardia Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate ... mini sandp 500td withdrawal limit atm 2023 BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for … cryptocurrency penny stock BioCardia stock has received a consensus rating of buy. The average rating score is and is based on 9 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for BioCardia stock? Nov 16, 2023 · BioCardia, Inc. announced a definitive agreement with a healthcare-focused institutional investor for the purchase and sale of 2,000,000 shares of the Company’s common stock at a purchase price of $0.65 per share in a registered direct offering. 2023 BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval. 16 Nov 2023 BioCardia Announces $1.3 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules.